Cleared Traditional

K050686 - CARDIOVIT AT-10PLUS

K050686 is an FDA 510(k) clearance for CARDIOVIT AT-10PLUS, manufactured by Schiller AG. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 49-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2005
Decision
49d
Days
Class 2
Risk

K050686 is an FDA 510(k) clearance for the CARDIOVIT AT-10PLUS. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Schiller AG (Baar, CH). The FDA issued a Cleared decision on May 4, 2005 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Schiller AG devices

FDA 510(k) Submission Details - K050686

510(k) Number K050686 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 16, 2005
Decision Date May 04, 2005
Days to Decision 49 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 125d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 471
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K050686.
READMYHEART, MODEL RMH3.0
K050620 · Dailycare Biomedical, Inc. · Jul 2005
ASCENTIA HEARTSTATION ECG MANAGEMENT SYSTEM
K050858 · Heartlab, Inc. · Jun 2005
CARDIOSCOPE SONOPLUS 3000
K051126 · Pulsonic Ag, Medical Technology · May 2005
MONEBO AUTOMATIC ARRHYTHMIA DETECTION SOFTWARE LIBRARY, VERSION 1
K043380 · Monebo Technologies, Inc. · Apr 2005
12-LEAD RESTING ELECTROCARDIOGRAPH, MODELS CP100 & CP200
K050074 · Welch Allyn, Inc. · Mar 2005
LIBERTY SYSTEM
K043074 · Inovise Medical, Inc. · Feb 2005